Rogosin's new Dialysis and Kidney Care & Education Center in East New York, Brooklyn: Serving and Working with the Community for Better Health and Quality of Life

News provided by

May 12, 2017, 10:00 ET

BROOKLYN, N.Y., May 12, 2017 /PRNewswire-USNewswire/ -- The Rogosin Institute (Rogosin), one of the largest not for profit dialysis providers in the NYC area with ten dialysis centers or programs located in Manhattan, Brooklyn, Queens, and the Bronx, is pleased to announce the opening of its newest Dialysis and Kidney Care and Education Center at 2372 Linden Boulevard in East New York.

This East New York Center represents a new concept in kidney care in that it will not only provide dialysis services for those whose kidneys do not function, but also educational, preventive, and early diagnostic services for residents of East New York and Brownsville, Central Brooklyn, and Queens. It is truly a "dialysis center without walls," designed to meet community needs, while serving to promote better kidney health in partnership with local residents and primary care and specialist physicians.

Rogosin staff have already been working closely for more than a year with the Brooklyn Borough President's Office, community leadership, Brookdale University Hospital and Medical Center, Brownsville Multi-Service Family Center, and CAMBA, as well as faith-based, governmental, recreational, and other local leadership to form the Central Brooklyn Health Movement, the purpose of which is to encourage residents to take more responsibility for improving their own health. Rogosin believes that this approach represents the future of the delivery of health care, and is committed to bringing that future to life now. Brooklyn is where this can, and should, be happening.

The new Linden Boulevard facility offers a 28-station, state-of-the-art kidney dialysis program provided by a staff of dedicated physicians, nurses, technicians, social workers and dietitians. Its Kidney Care and Education Center, working in collaboration and coordination with many other organizations, will provide residents with a community resource for health education and prevention programs, including risk factor identification, screening, nutrition counseling, transplant awareness programs and management of early chronic kidney disease. Most importantly, the new Center will partner with the people themselves.

"This new Center will combine the provision of the very best in kidney care, while focusing also on health promotion, disease prevention, and health education to make a real difference in both the health and quality of life of the people and community with whom we will be working. We are privileged to be part of the East New York/Brownsville community and to be able to partner not only with the community but also the great organizations already serving the people here. Together, we can make a great difference for health and life!" commented Barry Smith, President and CEO of Rogosin.

"It is vital that Brooklynites have options to seek treatment and preventative information for kidney disease," said Brooklyn Borough President Eric L. Adams. "I applaud The Rogosin Institute for opening up their newest Dialysis and Kidney Care and Education Center in East New York. This facility will provide the local community and others in surrounding neighborhoods with early diagnostics, preventative care, and educational support that are so desperately needed in this part of Brooklyn. East New York is disproportionately affected by kidney disease, and I'm certain The Rogosin Institute will serve as a critical resource for many."

The Rogosin Institute Dialysis and Kidney Care and Education Center is located at 2372 Linden Blvd, East New York, Brooklyn with a 13,500 sq. ft. dialysis center. The Center will be fully operational on or about May 22, 2017.

About The Rogosin Institute
Rogosin is an independent not-for-profit treatment and research center affiliated with NewYork-Presbyterian Hospital (NYPH) and Weill Cornell Medicine. It is a Sponsored Member of the NewYork-Presbyterian Regional Hospital Network. Rogosin is one of the nation's leading centers for kidney disease, providing services from early stage disease to more serious problems requiring dialysis and transplantation. The Institute is unique in its combination of the best in clinical care with research into new and better ways to prevent and treat kidney disease, as well as the diseases that contribute to it, such as hypertension, diabetes, and lipid disorders. The Rogosin Institute is committed to produce a unique applicable model for optimal, cost-effective health care and health promotion.

For more information, view www.rogosin.org.

SOURCE Rogosin Institute